Enhanced Tissue Sampling Tool(s)
Solid Tumor Biopsy for Diagnosis and Profiling
UnknownActive
Key Facts
About D3Sciences
D3Sciences is tackling a fundamental bottleneck in oncology: the inadequacy of standard biopsy samples for advanced diagnostic and molecular testing. The company is developing tools designed to obtain larger, more representative tissue samples during image-guided biopsies, thereby enabling comprehensive tumor profiling and personalized treatment planning. By bridging the gap between diagnostic capabilities and sampling techniques, D3Sciences seeks to improve diagnostic accuracy, therapy specificity, and accelerate cancer research. Its value proposition centers on empowering the clinical team—oncologists, radiologists, and pathologists—with better tissue to 'do more' for patients.
View full company profile